Upregulated IFN-γ activity is hypothesized to enhance antigen presentation and promotes the accumulation of pathogenic autoantibodies, which is leading to the IFN-α signaling dysregulation and increasing the likelihood of preclinical progression to clinical SLE [8]. Here, IFNA1 is linked to systemic lupus erythematosus.